Gramiyaa, a cold-pressed oil brand, closed a Series A round of roughly Rs 18.65 crore this month, led by Optiscape Network Holdings with existing backers Homegrown Ventures and Campus Fund returning. It follows a Rs 7.2 crore pre-Series A the company raised in an earlier round. The headline is a small, clean funding story in a sector that doesn’t get much venture attention.
The harder story is underneath it. Cold-pressed oil is one of the most crowded trust claims in Indian D2C right now, and almost every brand in it is making the identical pitch.
Everyone is selling the same promise
Walk through the cold-pressed oil shelf, online or offline, and the copy is nearly interchangeable: no chemicals, no refining, wood-pressed or stone-pressed, traditional method, lab-tested purity. It’s a real and valuable claim - refined oil’s additive-heavy process is a legitimate concern for a lot of Indian households - but a claim that every competitor makes with equal confidence stops functioning as a differentiator. It becomes table stakes, and the brand that only repeats it is fighting on price the moment a bigger player with better margins decides to compete.
This is the actual risk in Gramiyaa’s category, and it’s a brand problem before it’s a distribution problem. A fresh round of capital can open more retail shelves and fund more performance marketing. It cannot, on its own, give a shopper a reason to pick this cold-pressed oil over the five others making the same promise at a similar price.
What actually earns belief in a commodity-adjacent category
The D2C food brands that have broken out of this trap generally did one of two things. They made the purity claim checkable instead of just statable - batch-level lab reports, visible sourcing, a traceable supply chain a skeptical customer can actually verify rather than take on faith. Or they attached the product to something more specific than “purity” alone: a regional pressing tradition, a particular crop or terroir, a founder story with enough texture that it can’t be copy-pasted onto a competitor’s label by the following quarter.
Both routes cost more discipline than they cost money. A lab report is cheap. Deciding to publish it on every batch, consistently, long after the first press cycle has moved on, is the part most founders in this category skip.
The round’s real test isn’t the next twelve months
Pre-Series A and Series A capital in a category like this usually goes to supply chain, retail presence, and working capital - the unglamorous parts of actually having product on shelves at the volume a growing brand needs. That’s necessary and it’s not what will decide whether Gramiyaa is still differentiated three years from now. The category is going to get more crowded, not less, as bigger FMCG players notice the same consumer shift toward “clean” edible oil that smaller brands have been betting on. The brand that survives that crowding will be the one that made its specific claim checkable before it had to compete with someone who can out-advertise it.